Left Ventricular Assist Device Implantation and Kidney Function: Chicken, Egg, or Omelet?

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, Tufts Medical Center, Boston, MA.
² Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.

Editorial

Bethany Roehm et al. Kidney Med. 2021.

. 2021 May 8;3(3):324-326.

doi: 10.1016/j.xkme.2021.04.003. eCollection 2021 May-Jun.

¹ Division of Nephrology, Department of Internal Medicine, Tufts Medical Center, Boston, MA.
² Division of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX.

No abstract available

Comment on

1. Raichlin E., Baibhav B., Lowes B.D. Outcomes in patients with severe preexisting renal dysfunction after continuous-flow left ventricular assist device implantation. ASAIO J. 2016;62(3):261–267. - PubMed
1. Yoshioka D., Takayama H., Colombo P.C. Changes in end-organ function in patients with prolonged continuous-flow left ventricular assist device support. Ann Thorac Surg. 2017;103(3):717–724. - PubMed
1. Topkara V.K., Coromilas E.J., Garan A.R. Preoperative proteinuria and reduced glomerular filtration rate predicts renal replacement therapy in patients supported with continuous-flow left ventricular assist devices. Circ Heart Fail. 2016;9(12) - PubMed
1. Brisco M.A., Kimmel S.E., Coca S.G. Prevalence and prognostic importance of changes in renal function after mechanical circulatory support. Circ Heart Fail. 2014;7(1):68–75. - PMC - PubMed
1. Rose E.A., Gelijns A.C., Moskowitz A.J. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–1443. - PubMed